Close

Tonix Pharma (TNXP) Issues Positive Update from End-of-Phase 2/Pre-Phase 3 FDA Meeting for TNX-102 SL in PTSD

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. TSLA
2. ENPH
3. TXN
4. BA
5. SPOT
6. META
7. V
8. IBM
9. KMB
10. HCP


Go back to Tonix Pharma (TNXP) Issues Positive Update from End-of-Phase 2/Pre-Phase 3 FDA Meeting for TNX-102 SL in PTSD

Tonix Pharmaceuticals (TNXP) Gains Following Positive FDA Update on TNX-102 SL in PTSD

August 29, 2016 8:39 AM EDT

Tonix Pharmaceuticals (NASDAQ: TNXP) is gaining 15.6% early after the company announced... More